14:36:41 EST Sat 27 Feb 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

C:RVV - Revive Therapeutics Ltd. - http://www.revivethera.com14:36:41 EST
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RVV - C  47.10.50·0.517.00.51+0.0510.93,154.11,4951,3030.46  0.51  0.4450.92  0.0415:59:5810:4215 min RT 2¢
CSE - C47.10.50·0.517.00.51+0.0510.91,818.18656480.46  0.51  0.4450.92  0.0415:59:5815 min
NEO ATS - U 0.475+0.0153.3569.82682090.485  0.51  0.4513:34:1315 min
Omega - O 0.51+0.0510.9384.01841110.50  0.51  0.4515:59:4715 min
Chi-X - X 0.51+0.0510.951.724430.48  0.51  0.45515:59:1815 min
CX2 - H 0.50+0.048.7319.31482520.46  0.51  0.4515:58:1415 min
CXD - D 0.50+0.048.72.1160.50  0.50  0.5009:33:4015 min
TriAct - M 0.469.2434    Sep 08 15:05:2515 min

Recent Trades - Last 10 of 1303
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:58C0.510.05887 TD Sec7 TD SecE
15:59:58C0.510.052127 TD Sec85 ScotiaE
15:59:58C0.510.054,0007 TD Sec7 TD SecK
15:59:57C0.500.0450079 CIBC1 AnonymousK
15:59:57C0.510.052,0001 Anonymous9 BMO NesbittK
15:59:57C0.510.051,0001 Anonymous7 TD SecK
15:59:57C0.510.051,5001 Anonymous7 TD SecK
15:59:47O0.510.0550085 Scotia1 AnonymousK
15:59:47C0.510.0550085 Scotia85 ScotiaK
15:59:47C0.510.0550085 Scotia85 ScotiaK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolPriceTypeHeadline
2021-02-26 10:42C:RVV0.46News ReleaseRevive Therapeutics to expand bucillamine COVID study
2021-02-26 08:33C:RVV0.46News ReleaseRevive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
2021-02-17 11:09C:RVV0.62News ReleaseRevive to acquire psilocybin IP for $10-million
2021-02-12 10:14C:RVV0.69News ReleaseRevive closes $23-million prospectus offering
2021-02-11 09:41C:RVV0.60News ReleaseRevive talks cannabinoid pharmaceuticals program
2021-02-09 17:06C:RVV0.54News ReleaseRevive receives receipt for final prospectus
2021-02-09 15:52C:RVV0.53SEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus
2021-02-08 17:46C:RVV0.53News ReleaseRevive Therapeutics files report on Psilocin agreement